Stability-indicating RP-HPLC method for the simultaneous determination of escitalopram oxalate and clonazepam

Journal of Chromatographic Science

Volumn 51, Issue 6, 2013, Pages 490-495

  Kakde, Rajendra B ^a   Satone, Dinesh D ^a   Gadapayale, Kamalesh K ^a   Kakde, Megha G ^a  

^a RTM NAGPUR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLONAZEPAM;

ARTICLE; CHEMISTRY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; REPRODUCIBILITY; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; TABLET;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; CITALOPRAM; CLONAZEPAM; DRUG STABILITY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TABLETS;

EID: 84878846825     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/bms177     Document Type: Article

References (17)

1. British Pharmacopoeia; The Stationery Office, London, UK; (2003); pp. 712-718.
2. The United States Pharmacopoeia 32; The National Formulary 27; United States Pharmacopoeial Convention, (2009); pp. 1948-1949.
3. Parfait, K.; Martindale, The complete drug reference, Pharmaceutical Press London; (1999); 32: 914.
4. Gandhi, S.V., Dhavale, N.D., Jadhav, V.Y., Sabnis, S.S.; Spectrophotometric and reverse phase high performance liquid chromatographic method for simultaneous estimation of escitalopram oxalate and clonazepam in combined tablet dosage form; Journal of AOAC International, (2008); 91: 71-75.
5. Dhavale, N., Gandhi, S., Sabnis, S., Bothara, K.; Simultaneous HPTLC determination of escitalopram oxalate and clonazepam in combined tablet; Chromatographia, (2008); 67: 487-490.
6. Kakde, R.B., Satone, D.D., Bawane, N.N.; HPTLC method for simultaneous determination of escitalopram oxalate and clonazepam in pharmaceutical preparations; Journal of Planar Chromatography, (2009); 22: 417-420.
7. Kakde, R.B., Satone, D.D.; Spectrophotometric method for simultaneous estimation of escitalopram oxalate and clonazepam in tablet dosage form; Indian Journal of Pharmaceutical Science, (2009); 71: 701-704.
8. Sharma, S., Rajput, H., Sonwal, C., Choudhary, V.R., Jain, T.; Zero order spectrophotometric method for estimation of escitalopram oxalate in tablet formulation; Journal of Young Pharmacist, (2010); 2: 420-423.
9. Bares, I.F., Pebienne, F., Christian, J.; Development of a rapid RP-HPLC method for the determination of clonazepam in human plasma; Journal of Pharmaceutical and Biomedical Analysis, (2004); 36: 865-869.
10. Randez-Gil, J.A., Daros, A.S., Guardia, M.D.L.; Direct derivative spectrophotometric determination of nitrazepam and clonazepam in biological fluids; Journal of Pharmaceutical and Biomedical Analysis, (1991); 9: 539-545.
11. ICH, Q1AR2 Stability testing of new drug substances and products, International Conference on Harmonization, IFPMA, Geneva, (2000).
12. ICH, Stability testing of new drug substances and products, International Conference on Harmonization, IFPMA, Geneva, (2003).
13. Singh, S., Bakshi, M.; Guidance on conduct of stress tests to determine inherent stability of drugs; Pharmaceutical Technology, (2000); 24: 1-14.
14. Bakshi, M., Singh, S.; Development of validated stability-indicating assay methods critical review; Journal of Pharmaceutical and Biomedical Analysis, (2002); 28: 1011-40.
15. ICH, Stability testing: Photostability testing of new drug substances and products. International Conference on Harmonization, IFPMA, Geneva, (1996).
16. Validation of Compendial Methods, The United States Pharmacopeia, (2000); 24.
17. Krull, I., Swartz, M.; Validation viewpoint, introduction national and international guidelines; LC-GC, (1997); 15(6): 534-39.